BSX
Boston Scientific Corp.
Company · XNYS · US · USD
Market price
$44.80
+$0.60 (+1.36%) · 3 months
| Date and time | Price |
|---|---|
| Jun 25, 2026 | $44.20 |
| Jun 26, 2026 | $44.23 |
| Jun 29, 2026 | $43.48 |
| Jun 30, 2026 | $42.68 |
| Jul 1, 2026 | $43.06 |
| Jul 2, 2026 | $45.14 |
| Jul 6, 2026 | $44.60 |
| Jul 7, 2026 | $45.30 |
| Jul 8, 2026 | $44.81 |
| Jul 9, 2026 | $44.99 |
| Jul 10, 2026 | $44.77 |
| Jul 13, 2026 | $44.65 |
| Jul 14, 2026 | $42.63 |
| Jul 15, 2026 | $43.04 |
| Jul 16, 2026 | $44.62 |
| Jul 17, 2026 | $44.03 |
| Jul 20, 2026 | $43.77 |
| Jul 21, 2026 | $43.19 |
| Jul 22, 2026 | $42.97 |
| Jul 23, 2026 | $43.58 |
| Jul 24, 2026 | $44.25 |
| Jul 27, 2026 | $45.51 |
| Jul 28, 2026 | $46.06 |
| Jul 29, 2026 | $46.04 |
| Jul 30, 2026 | $46.00 |
| Jul 31, 2026 | $46.73 |
| Aug 3, 2026 | $48.43 |
| Aug 4, 2026 | $49.09 |
| Aug 5, 2026 | $47.74 |
| Aug 6, 2026 | $49.30 |
| Aug 7, 2026 | $49.31 |
| Aug 10, 2026 | $50.46 |
| Aug 11, 2026 | $51.19 |
| Aug 12, 2026 | $51.42 |
| Aug 13, 2026 | $51.69 |
| Aug 14, 2026 | $51.83 |
| Aug 17, 2026 | $51.43 |
| Aug 18, 2026 | $50.47 |
| Aug 19, 2026 | $52.01 |
| Aug 20, 2026 | $49.37 |
| Aug 21, 2026 | $50.37 |
| Aug 24, 2026 | $49.01 |
| Aug 25, 2026 | $49.86 |
| Aug 26, 2026 | $48.17 |
| Aug 27, 2026 | $46.67 |
| Aug 28, 2026 | $46.84 |
| Aug 31, 2026 | $48.30 |
| Sep 1, 2026 | $48.08 |
| Sep 2, 2026 | $48.37 |
| Sep 3, 2026 | $46.95 |
| Sep 4, 2026 | $47.80 |
| Sep 8, 2026 | $44.98 |
| Sep 9, 2026 | $44.96 |
| Sep 10, 2026 | $43.10 |
| Sep 11, 2026 | $42.98 |
| Sep 14, 2026 | $45.05 |
| Sep 15, 2026 | $43.87 |
| Sep 16, 2026 | $43.91 |
| Sep 17, 2026 | $43.55 |
| Sep 18, 2026 | $43.34 |
| Sep 21, 2026 | $43.72 |
| Sep 22, 2026 | $44.92 |
| Sep 23, 2026 | $44.62 |
| Sep 24, 2026 | $44.80 |
- Period change
- +1.36%
- Period low
- $42.63
- Period high
- $52.01
- Observations
- 64
- Updated
- Sep 24, 2026, 8:00 PM
About Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $63,360,314,876.72
- Employees
- 59K